HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of highly sulfated keratan sulfate synthesized in human glioblastoma cells.

Abstract
Keratan sulfate (KS) proteoglycan is expressed in the extracellular matrix or cell surface in numerous tissues, predominantly in those of the cornea, cartilage, and brain. However, its structure, function, and regulation remain poorly understood. Our investigation of KS expression in glioblastoma cell lines using Western-blot and flow cytometry with anti-KS antibody (5D4) revealed that LN229 glioblastoma cell highly expresses KS on a cell surface. Real-time PCR analysis showed that LN229 expresses a high level of keratan sulfate Gal-6-sulfotransferase. Results of this study also demonstrate that recombinant 5D4-reactive aggrecan is produced in LN229. Taken together, these results suggest that LN229 produces 5D4-reactive highly sulfated KS and is useful to investigate the KS structure and function in glioblastoma.
AuthorsNorihito Hayatsu, Satoshi Ogasawara, Mika Kato Kaneko, Yukinari Kato, Hisashi Narimatsu
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 368 Issue 2 Pg. 217-22 (Apr 04 2008) ISSN: 1090-2104 [Electronic] United States
PMID18211804 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Proteoglycans
  • Sulfates
  • Keratan Sulfate
Topics
  • Cell Line, Tumor
  • Gene Expression Regulation, Neoplastic
  • Glioblastoma (metabolism)
  • Humans
  • Keratan Sulfate (metabolism)
  • Proteoglycans (metabolism)
  • Sulfates (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: